Rankings
▼
Calendar
CGEN Q4 2022 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena
CGEN
Compugen Ltd.
$202M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
Gross Profit
$7M
87.0% margin
Operating Income
-$4M
-47.1% margin
Net Income
-$3M
-41.2% margin
EPS (Diluted)
$-0.04
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$94M
Total Liabilities
$16M
Stockholders' Equity
$78M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$0
—
Gross Profit
$7M
$0
—
Operating Income
-$4M
-$9M
+59.8%
Net Income
-$3M
-$9M
+64.2%
← FY 2022
All Quarters
Q1 2023 →